SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
5.38
+0.18 (3.46%)
Mar 20, 2026, 11:14 AM EDT - Market open

SLS Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
---17.6
Revenue Growth (YoY)
----86.84%300.00%
Cost of Revenue
---0.10.2
Gross Profit
---0.97.4
Selling, General & Admin
12.2512.4213.8612.5811.32
Research & Development
16.0219.124.0120.2715.67
Other Operating Expenses
---105.7
Total Operating Expenses
28.2731.5137.8742.8532.69
Operating Income
-28.27-31.51-37.87-41.95-25.29
Interest Income
1.410.630.530.320.01
Other Non-Operating Income (Expense)
--00.334.35
Total Non-Operating Income (Expense)
1.410.630.530.654.36
Pretax Income
-26.86-30.88-37.34-41.3-20.94
Provision for Income Taxes
-----0.24
Net Income
-26.86-30.88-37.34-41.3-20.7
Net Income to Common
-26.86-30.88-37.34-41.3-20.7
Shares Outstanding (Basic)
10961281915
Shares Outstanding (Diluted)
10961281915
Shares Change (YoY)
78.18%120.33%43.21%25.29%94.07%
EPS (Basic)
-0.25-0.50-1.34-2.13-1.34
EPS (Diluted)
-0.25-0.50-1.34-2.13-1.34
Free Cash Flow
-28.39-35.4-31.41-23.81-26.02
Free Cash Flow Per Share
-0.26-0.58-1.13-1.23-1.68
Gross Margin
---90.00%97.37%
Operating Margin
----4195.00%-332.82%
Profit Margin
----4130.10%-272.36%
FCF Margin
----2380.90%-342.38%
EBITDA
-28.27-31.51-37.87-41.95-25.29
EBIT
-28.27-31.51-37.87-41.95-25.29
EBIT Margin
----4195.00%-332.82%
Effective Tax Rate
0.00%0.00%0.00%0.00%1.13%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q